Gran­flu­encers and boom­flu­encers: Is the hip­ster old­ster so­cial me­dia trend mov­ing to phar­ma?

Cathy Chester’s lat­est In­sta­gram post is about her ex­pe­ri­ence be­ing preg­nant while hav­ing mul­ti­ple scle­ro­sis — in 1992. That was six years af­ter her ini­tial di­ag­no­sis and one year be­fore Be­taseron be­came the first FDA-ap­proved drug to treat the un­der­ly­ing dis­ease in re­laps­ing-re­mit­ting MS.

Chester, now 63, writes about how a few years be­fore she be­came preg­nant, when she was con­sid­er­ing get­ting mar­ried, she drove more than 90 min­utes to hear a spe­cial­ist talk about MS and preg­nan­cy. Be­cause the in­ter­net was still emerg­ing then, and mod­ern smart­phones were on­ly a twin­kle in Ap­ple’s eye, she couldn’t just “look it up.” And her doc­tors back then weren’t as open to lis­ten­ing to pa­tients’ per­son­al is­sues as they are to­day.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.